Cancer chemotherapeutic agents.
Clinicians, in general, must understand the causes, methods of prevention, management principles, and complications of cancer therapy. They must recognize that patients with cancer require multidisciplinary treatment and coordination of care. The oncologist who manages the patient's care must involve the oral health care provider before the initiation of chemotherapy. The oral health care provider must recognize that cancer chemotherapeutic agents are not selectively tumoricidal and may produce adverse effects by direct toxicity at the cellular level or indirectly, characterized by myeloimmunosuppression, and has the obligation to deliver quality care, competently and timely before, during, and after cancer chemotherapy.
Terezhalmy
G T
GT
Department of Dentistry, Cleveland Clinic Foundation, Ohio, USA.
Whitmyer
C C
CC
Markman
M
M
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects; D017742:Dental Care for Chronically Ill; D003815:Dentists; D006801:Humans; D008495:Medical Oncology; D009059:Mouth Diseases / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy; D010347:Patient Care Planning; D010348:Patient Care Team; D011787:Quality of Health Care
D000970:Antineoplastic Agents